Skip to main content
Erschienen in: International Urogynecology Journal 2/2022

24.03.2021 | Original Article

Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse

verfasst von: Chia-Lun Chang, Chun-Hua Chen, Shang-Jen Chang

Erschienen in: International Urogynecology Journal | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Abdominal sacrocolpopexy is regarded as the gold standard for management of pelvic organ prolapse (POP). Nowadays, minimally invasive surgeries are preferred, and sacrocolpopexy can be performed using either a laparoscopic or robotic-assisted approach. The aim of the current study was to compare the efficacy and safety of robotic-assisted sacrocolpopexy (RASC) and laparoscopic sacrocolpopexy (LSC) through an updated systematic review and meta-analysis.

Methods

We performed a systematic literature review of different databases and related references from their inception until July 2020 without language restrictions. All randomized control trials and comparative studies that compared RASC and LSC for the management of POP were included.

Results

A total of 13 studies including 2115 participants were included for the pooled analysis. The pooled results revealed that RASC was associated with a significantly longer operative time (weighted mean difference, 29.53 min; 95% confidence interval [CI], 12.88 to 46.18 min, P = 0.0005), significantly less estimated blood loss (weighted mean difference, −86.52 ml; 95% CI −130.26 to −42.79 ml, P = 0.0001), significantly fewer overall intraoperative complications (odds ratio [OR] 0.6; 95% CI 0.40 to 0.91; P = 0.01) and significantly lower conversion rate (OR 0.39; 95% CI 0.19 to 0.82; P = 0.01) compared with LSC. There were no significant differences between the length of hospital stays, overall postoperative complications, postoperative stress incontinence, mesh erosion and effectiveness between the two groups.

Conclusion

The current study showed comparable efficacy between RASC and LSC. Though RASC was associated with less blood loss and a lower conversion rate, the differences were not clinically significant. The choice of surgical procedure with either RASC or LSC is according to surgeon discretion and patient preferences.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90.CrossRef Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90.CrossRef
2.
Zurück zum Zitat Fleischer K, Thiagamoorthy G. Pelvic organ prolapse management. Post Reprod Health. 2020;26(2):79–85.CrossRef Fleischer K, Thiagamoorthy G. Pelvic organ prolapse management. Post Reprod Health. 2020;26(2):79–85.CrossRef
3.
Zurück zum Zitat Ng-Stollmann N, et al. The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J. 2020;31(10):1997–2002.CrossRef Ng-Stollmann N, et al. The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J. 2020;31(10):1997–2002.CrossRef
4.
Zurück zum Zitat Nosti PA, et al. Outcomes of abdominal and minimally invasive sacrocolpopexy: a retrospective cohort study. Female Pelvic Med Reconstr Surg. 2014;20(1):33–7.CrossRef Nosti PA, et al. Outcomes of abdominal and minimally invasive sacrocolpopexy: a retrospective cohort study. Female Pelvic Med Reconstr Surg. 2014;20(1):33–7.CrossRef
5.
Zurück zum Zitat De Gouveia De Sa, M., et al. Robotic versus laparoscopic sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis. Int Urogynecol J Pelvic Floor Dysfunction. 2016;27(3):355–366.CrossRef De Gouveia De Sa, M., et al. Robotic versus laparoscopic sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis. Int Urogynecol J Pelvic Floor Dysfunction. 2016;27(3):355–366.CrossRef
6.
Zurück zum Zitat Pan K, et al. A systematic review and meta-analysis of conventional laparoscopic sacrocolpopexy versus robot-assisted laparoscopic sacrocolpopexy. Int J Gynecol Obstet. 2016;132(3):284–91.CrossRef Pan K, et al. A systematic review and meta-analysis of conventional laparoscopic sacrocolpopexy versus robot-assisted laparoscopic sacrocolpopexy. Int J Gynecol Obstet. 2016;132(3):284–91.CrossRef
7.
Zurück zum Zitat Illiano E, et al. Robot-assisted vs laparoscopic sacrocolpopexy for high-stage pelvic organ prolapse: a prospective, randomized, single-center study. Urology. 2019;134:116–23.CrossRef Illiano E, et al. Robot-assisted vs laparoscopic sacrocolpopexy for high-stage pelvic organ prolapse: a prospective, randomized, single-center study. Urology. 2019;134:116–23.CrossRef
8.
Zurück zum Zitat Mueller MG, et al. Outcomes in 450 women after minimally invasive abdominal sacrocolpopexy for pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2016;22(4):267–71.CrossRef Mueller MG, et al. Outcomes in 450 women after minimally invasive abdominal sacrocolpopexy for pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2016;22(4):267–71.CrossRef
9.
Zurück zum Zitat Unger CA, et al. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547.e1–8.CrossRef Unger CA, et al. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547.e1–8.CrossRef
10.
Zurück zum Zitat Cucinella G, et al. Robotic versus laparoscopic sacrocolpopexy for apical prolapse: a case-control study. Il Giornale di chirurgia. 2016;37(3):113–7.PubMedPubMedCentral Cucinella G, et al. Robotic versus laparoscopic sacrocolpopexy for apical prolapse: a case-control study. Il Giornale di chirurgia. 2016;37(3):113–7.PubMedPubMedCentral
11.
Zurück zum Zitat Bump RC, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef Bump RC, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef
12.
Zurück zum Zitat Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRef Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRef
13.
Zurück zum Zitat Borenstein M, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.CrossRef Borenstein M, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.CrossRef
14.
Zurück zum Zitat Paraiso MF, et al. Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. Obstet Gynecol. 2011;118(5):1005–13.CrossRef Paraiso MF, et al. Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. Obstet Gynecol. 2011;118(5):1005–13.CrossRef
15.
Zurück zum Zitat Anger JT, et al. Robotic compared with laparoscopic sacrocolpopexy: a randomized controlled trial. Obstet Gynecol. 2014;123(1):5–12.CrossRef Anger JT, et al. Robotic compared with laparoscopic sacrocolpopexy: a randomized controlled trial. Obstet Gynecol. 2014;123(1):5–12.CrossRef
16.
Zurück zum Zitat Seror J, et al. Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy. World J Urol. 2012;30(3):393–8.CrossRef Seror J, et al. Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy. World J Urol. 2012;30(3):393–8.CrossRef
17.
Zurück zum Zitat Awad N, et al. Implementation of a new procedure: laparoscopic versus robotic sacrocolpopexy. Arch Gynecol Obstet. 2013;287(6):1181–6.CrossRef Awad N, et al. Implementation of a new procedure: laparoscopic versus robotic sacrocolpopexy. Arch Gynecol Obstet. 2013;287(6):1181–6.CrossRef
18.
Zurück zum Zitat Antosh DD, et al. Short-term outcomes of robotic versus conventional laparoscopic sacral colpopexy. Female Pelvic Med Reconstr Surg. 2012;18(3):158–61.CrossRef Antosh DD, et al. Short-term outcomes of robotic versus conventional laparoscopic sacral colpopexy. Female Pelvic Med Reconstr Surg. 2012;18(3):158–61.CrossRef
19.
Zurück zum Zitat Pulliam SJ, Weinstein MM, Wakamatsu MM. Minimally invasive apical sacropexy: a retrospective review of laparoscopic and robotic operating room experiences. Female Pelvic Med Reconstr Surg. 2012;18(2):122–6.CrossRef Pulliam SJ, Weinstein MM, Wakamatsu MM. Minimally invasive apical sacropexy: a retrospective review of laparoscopic and robotic operating room experiences. Female Pelvic Med Reconstr Surg. 2012;18(2):122–6.CrossRef
20.
Zurück zum Zitat Tan-Kim J, et al. Robotic-assisted and laparoscopic sacrocolpopexy: comparing operative times, costs and outcomes. Female Pelvic Med Reconstr Surg. 2011;17(1):44–9.CrossRef Tan-Kim J, et al. Robotic-assisted and laparoscopic sacrocolpopexy: comparing operative times, costs and outcomes. Female Pelvic Med Reconstr Surg. 2011;17(1):44–9.CrossRef
21.
Zurück zum Zitat Chan SSC, et al. Laparoscopic sacrocolpopexy for the treatment of vaginal vault prolapse: with or without robotic assistance. Hong Kong Medical Journal. 2011;17(1):54–60.PubMed Chan SSC, et al. Laparoscopic sacrocolpopexy for the treatment of vaginal vault prolapse: with or without robotic assistance. Hong Kong Medical Journal. 2011;17(1):54–60.PubMed
22.
Zurück zum Zitat Choussein S, et al. Robotic assistance confers ambidexterity to laparoscopic surgeons. J Minim Invasive Gynecol. 2018;25(1):76–83.CrossRef Choussein S, et al. Robotic assistance confers ambidexterity to laparoscopic surgeons. J Minim Invasive Gynecol. 2018;25(1):76–83.CrossRef
23.
Zurück zum Zitat Truong M, et al. Advantages of robotics in benign gynecologic surgery. Curr Opin Obstet Gynecol. 2016;28(4):304–10.CrossRef Truong M, et al. Advantages of robotics in benign gynecologic surgery. Curr Opin Obstet Gynecol. 2016;28(4):304–10.CrossRef
Metadaten
Titel
Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse
verfasst von
Chia-Lun Chang
Chun-Hua Chen
Shang-Jen Chang
Publikationsdatum
24.03.2021
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 2/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-021-04741-x

Weitere Artikel der Ausgabe 2/2022

International Urogynecology Journal 2/2022 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.